Back to companies
Cartesian Therapeutics, Inc.
RNACUSNASDAQPharmaceuticals & HealthcareCartesian Therapeutics, Inc.
Revenue
$400,000
YoY -99.0%
Operating income
-$143.4mn
FY2025
Employees
—
Founded
—
Source: U.S. Securities and Exchange Commission (SEC) EDGAR Company Facts API